三、三级预防

三、三级预防

鼻咽癌的三级预防，指给予鼻咽癌患者合适的个体化的治疗，以改善预后，提高生存质量，延长寿命，降低死亡率。主要包括对症治疗，可以改善症状、减少疾病的不良反应，防止肿瘤的复发转移，预防并发症等。

康复治疗的措施包括心理康复、社会康复和职业康复，应该普及鼻咽癌的科普知识，专门为病人开设健康心理咨询，及时排查患者的各种负面消极情绪和思想，开导病人，促使其树立积极的生活态度。

（曹素梅　郭　灵）

第一章参考文献

1.Waterhouse J , M C S , Shanmugaratnam K , Powell J , eds.Cancer Incidence in Five Continents, Vol.Ⅳ.IARC Scientific Publications Lyon, No.42, IARC.1982.

2.Muir C S , W J , Mack T , Powell J , Whelan S L , eds.Cancer Incidence in Five Continents, Vol.V.IARC Scientifi c Publications No.88, Lyon, IARC.1987.

3.Parkin D M , M C S , Whelan S L , Gao Y T , Ferlay J , Powell J , eds.Cancer Incidence in Five Continents, Vol.Ⅵ.IARC Scientifi c Publications No.120, Lyon, IARC.1992.

4.Parkin D M , W S L , Ferlay J , Teppo L., Thomas D B , eds.Cancer Incidence in Five Continents, Vol.VIII IARC Scientifi c Publications No.155, Lyon, IARC.2002.

5.Zong Y S , Zhang R F , He S Y , and Qiu H.Histopathologic types and incidence of malignant nasopharyngeal tumors in Zhongshan County.Chin Med J(Eng), 96: 511-516, 1983.

6.Burt R D , Vaughan T L , and McKnight B.Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States.Int J Cancer, 52: 549-556, 1992.

7.Li C C , Yu M C , and Henderson B E.Some epidemiologic observations of nasopharyngeal carcinoma in Guangdong, People's Republic of China.Natl Cancer Inst Monogr, 69: 49-52, 1985.

8.Armstrong　R W , Kannan Kutty M , Dharmalingam S K , and Ponnudurai J R.Incidence of nasopharyngeal carcinoma in Malaysia, 1968-1977.Br J Cancer, 40: 557-567, 1979.

9.McCredie M , Williams S , and Coates M Cancer mortality in East and Southeast Asian migrants to New South Wales, Australia, 1975-1995.Br J Cancer, 79: 1277-1282, 1999.

10.Parkin D M and Iscovich J.Risk of cancer in migrants and their descendants in Israel: II.Carcinomas and germ-cell tumours.Int J Cancer, 70: 654-660, 1997.

11.Warnakulasuriya K.A., Johnson N.W., Linklater K.M., and Bell J.Cancer of mouth, pharynx and nasopharynx in Asian and Chinese immigrants resident in Thames regions.Oral Oncol, 35: 471-475, 1999.

12.Buell P.Race and place in the etiology of nasopharyngeal cancer: a study based on California death certifi cates.Int J Cancer, 11: 268-272, 1973.

13.Jeannel D , Ghnassia M , Hubert A , Sancho-Garnier H , Eschwege F , Crognier E , and de-The G.Increased risk of nasopharyngeal carcinoma among males of French origin born in Maghreb (north Africa).Int J Cancer, 54: 536-539, 1993.

14.Vaughan T L , Shapiro J A , Burt R D , Swanson G M , Berwick M , Lynch C F , and Lyon J L.Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type.Cancer Epidemiol Biomarkers Prev, 5: 587-593, 1996.

15.Yu M C , Ho J H , Lai S H , and Henderson B E.Cantonese-style salted fi sh as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong.Cancer Res, 46: 956-961, 1986.

16.Yu M C , Garabrant D H , Huang T B , and Henderson B E.Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China.Int J Cancer, 45: 1033-1039, 1990.

17.Albeck H , Bentzen J , Ockelmann H H , Nielsen N H , Bretlau, P , and Hansen H S.Familial clusters of nasopharyngeal carcinoma and salivary gland carcinomas in Greenland natives.Cancer, 72: 196-200, 1993.

18.Yuan J M , Wang X L , Xiang Y B , Gao Y T , Ross R K , and Yu M C.Nondietary risk factors for nasopharyngeal carcinoma in Shanghai, China.Int J Cancer, 85: 364-369, 2000.

19.Yue Liu Q H , Wanli Liu, Qing Liu, Weihua Jia, Ellen T Chang, Feng Chen, Zhiwei Liu, Xiang Guo, Haoyuan Mo, Jinou Chen, Dongping and Rao, W Y , Sumei Cao, Minghuang Hong.Establishment of VCA and EBNA1 IgA-based Combination by Enzyme-linked Immunosorbent Assay as Preferred Screening Method for Nasopharyngeal Carcinoma: A Two-Stage Design with a Preliminary Performance Study and a Mass Screening in Southern China.International Journal of Cancer.(Accepted), 2005.

20.Lee A W , Foo W , Mang O , Sze W M , Chappell R , Lau W H , and Ko W M Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality.Int J Cancer, 103: 680-685, 2003.

21.Hsu C , Shen Y C , Cheng C C , Hong R L , Chang C J , and Cheng A L Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis.Cancer Epidemiol Biomarkers Prev, 15: 856-861, 2006.

22.Luo J , Chia K S , Chia S E , Reilly M , Tan C S , and Ye W.Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997.Eur J Epidemiol, 22: 513-521, 2007.(https://www.daowen.com)

23.Sun L M , Epplein M, Li C I , Vaughan T L , and Weiss N S.Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002.Am J Epidemiol, 162: 1174-1178, 2005.

24.Wang H , Seow A , and Lee H P.Trends in cancer incidence among Singapore Malays: a low-risk population.Ann Acad Med Singapore, 33: 57-62, 2004.

25.Jia W H , Huang Q H , Liao J , Ye W , Shugart Y Y , Liu Q , Chen L Z , Li Y H , Lin X , Wen F L , Adami H O , Zeng Y , and Zeng Y X.Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.BMC Cancer, 6: 178, 2006.

26.Tse L A , Yu I T , Mang O W , and Wong S L.Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong.Br J Cancer, 95: 1269-1273, 2006.

27.Old L J , Boyse E A , Oettgen H F , Harven E D , Geering G , Williamson B , and Clifford P.Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.Proc Natl Acad Sci U.S.A, 56: 1699-1704, 1966.

28.Chien Y C , Chen J Y , Liu M Y , Yang H I , Hsu M M , Chen C J , and Yang C S.Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.N Engl J Med, 345: 1877-1882, 2001.

29.Ji M F , Wang D K , Yu Y L , Guo Y Q , Liang J S , Cheng W M , Zong Y S , Chan K H , Ng S P , Wei W I , Chua D T , Sham J S , and Ng M H.Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.Br J Cancer, 96: 623-630, 2007.

30.Friborg J T , Yuan J M , Wang R , Koh W P , Lee H P , and Yu M C.A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese.Cancer, 109: 1183-1191, 2007.

31.Stowe R P , Pierson D L , and Barrett A D.Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts.Psychosom Med, 63: 891-895, 2001.

32.Yu M C , Huang T B , and Henderson B E.Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China.Int J Cancer, 43: 1077-1082, 1989.

33.Lee, H.P., Gourley, L., Duffy, S.W., Esteve, J., Lee, J., and Day, N.E.Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese.Int J Cancer, 59: 585-590, 1994.

34.Nam J M , McLaughlin J K , and Blot W J.Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S.whites.J Natl Cancer Inst, 84: 619-622, 1992.

35.Hildesheim A , Apple R J , Chen C J , Wang S S , Cheng Y J , Klitz W , Mack S J , Chen I H , Hsu M M , Yang C S , Brinton L A , Levine P H , and Erlich H A.Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan.J Natl Cancer Inst, 94: 1780-1789, 2002.

36.Kongruttanachok N , Sukdikul S , Setavarin S , Kerekhjanarong V , Supiyaphun P , Voravud N , Poovorawan Y , and Mutirangura A.Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study.BMC Cancer, 1: 4, 2001.

37.Hildesheim A , Chen C J , Caporaso N E , Cheng Y J , Hoover R N , Hsu M M , Levine P H , Chen I H , Chen J Y , Yang C S , and et al.Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a casecontrol study conducted in Taiwan.Cancer Epidemiol Biomarkers Prev, 4: 607-610, 1995.

38.Nazar-Stewart V , Vaughan T L , Burt R D , Chen C , Berwick M , and Swanson G M.Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma.Cancer Epidemiol Biomarkers Prev, 8: 547-551, 1999.

39.Feng B J , Huang W , Shugart Y Y , Lee M K , Zhang F , Xia J C , Wang H Y , Huang T B , Jian S W , Huang P , Feng Q S , Huang L X , Yu X J , Li D , Chen L Z , Jia W H , Fang Y , Huang H M , Zhu J L , Liu X M , Zhao Y , Liu W Q , Deng M Q , Hu W H , Wu S X , Mo H Y , Hong M F , King M C , Chen Z , and Zeng Y X Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.Nat Genet, 31: 395-399, 2002.

40.Zheng Y M , Tuppin P , Hubert A , Jeannel D , Pan Y J , Zeng Y , and de The, G.Environmental and dietary risk factors for nasopharyngeal carcinoma: a casecontrol study in Zangwu County, Guangxi, China.Br J Cancer, 69: 508-514, 1994.

41.Hildesheim A , West S , DeVeyra E , De Guzman M F , Jurado A , Jones C , Imai J , and Hinuma Y.Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.Cancer Res, 52: 3048-3051, 1992.

42.Tang W P , Huang P G , Zhao M L , Liao S L , and Zeng Y.Wikstroemia indica promotes development of nasopharyngeal carcinoma in rats initiated by dinitrosopiperazine.J Cancer Res Clin Oncol, 114: 429-431, 1988.

43.Luce D , Leclerc A , Begin D , Demers P A , Gerin M , Orlowski E , Kogevinas M , Belli S , Bugel I , Bolm-Audorff　U , Brinton L A , Comba P , Hardell L , Hayes R B , Magnani C , Merler E , Preston-Martin S , Vaughan T L , Zheng W , and Boffetta P.Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies.Cancer Causes Control, 13: 147-157, 2002.

44.Bolviken B , Flaten T P , Zheng C.Relations between nasopharyngeal carcinoma and magnesium and other alkaline earth elements in soils in China.Med Hypotheses, 48: 21-25, 1997.

45.姜春秋, 李安明, 刘元清,等.鼻咽癌患者心理社会因素多变量分析.武汉大学学报, 22(1): 32～34, 2001.

46.黄腾波, 汪慧民，李景廉，欧星泰，方积乾，刘克拉.鼻咽癌高危人群,癌前病变的确立.癌症　81～84,1997.

47.刘科，陈峰，黄启洪，李艳华，曹素梅.四会市筛查人群中鼻咽癌患者长期生存状况分析.中国肿瘤临床, 16(2): 630～633, 1997.

48.Liu Y , Huang Q , Liu W , Liu Q , Jia W , Chang E , Chen F , Liu Z , Guo X , Mo H , Chen J , Rao D , Ye W , Cao S , and Hong M.Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: A two-stage design with a preliminary performance study and a Mass screening in southern china.Int J Cancer.